Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

VelaVigo, founded by Dr. Jing Li in October 2021, is a biopharma company focused on innovative technologies like bispecific antibodies, ADC, and new modalities. The company develops a comprehensive drug discovery and development pipeline, from novel platforms to clinical commercialization. With a global presence and R&D headquarters in Shanghai, VelaVigo aims to deliver groundbreaking treatments worldwide. The name "VelaVigo...
VelaVigo, founded by Dr. Jing Li in October 2021, is a biopharma company focused on innovative technologies like bispecific antibodies, ADC, and new modalities. The company develops a comprehensive drug discovery and development pipeline, from novel platforms to clinical commercialization. With a global presence and R&D headquarters in Shanghai, VelaVigo aims to deliver groundbreaking treatments worldwide. The name "VelaVigo" reflects its mission to navigate global innovation in healthcare.

List your booth number for exhibitions, ask us